Cormorant Asset Management, LP Twist Bioscience Corp Transaction History

Cormorant Asset Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$95.64 - $131.48 $17.7 Million - $24.3 Million	-185,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$105.48 - $207.97 $4.22 Million - $8.32 Million	-40,000 Reduced 17.78%	185,000 $22.9 Million
Q4 2020 Feb 16, 2021	SELL	$76.64 - $167.89 $21.1 Million - $46.2 Million	-275,000 Reduced 55.0%	225,000 $31.8 Million
Q3 2020 Nov 16, 2020	SELL	$45.46 - $78.79 $2.4 Million - $4.16 Million	-52,849 Reduced 9.56%	500,000 $38 Million
Q2 2020 Aug 14, 2020	SELL	$26.4 - $45.3 $3.55 Million - $6.08 Million	-134,300 Reduced 19.54%	552,849 $25 Million
Q3 2019 Nov 14, 2019	SELL	$23.72 - $33.99 $448,663 - $642,920	-18,915 Reduced 2.68%	687,149 $16.4 Million
Q4 2018 Feb 14, 2019	BUY	$14.0 - $31.08 $9.88 Million - $21.9 Million	706,064 New	706,064 $16.3 Million

258

66.6M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.7B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.